William P. Sheridan
Corporate Officer/Principal presso BIOCRYST PHARMACEUTICALS, INC.
Patrimonio netto: 30 729 $ in data 31/03/2024
Profilo
William P.
Sheridan's current job is as the Chief Development Officer at BioCryst Pharmaceuticals, Inc. His former job was as the Vice President-North American Medical Affairs at Amgen, Inc. He also served as the Head-Bone Marrow Transplant Service at Royal Melbourne Hospital.
Dr. Sheridan holds a doctorate degree from the University of Melbourne.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2023 | 6 049 ( 0.00% ) | 30 729 $ | 31/03/2024 |
Posizioni attive di William P. Sheridan
| Società | Posizione | Inizio |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15/09/2022 |
Precedenti posizioni note di William P. Sheridan
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/11/2007 |
Royal Melbourne Hospital
 Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Formazione di William P. Sheridan
| University of Melbourne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Royal Melbourne Hospital
Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Health Services |
- Borsa valori
- Insiders
- William P. Sheridan
